Hey Fitz,
Turing Pharmaceuticals bought the marketing rights to Daraprim from Impax in 2015, and then promptly jacked the price from $13.50 to $750 per pill. This can only be described as a scandal. Since it happened in the USA, it seems fair enough to call it a "USA price hike scandal".
The price of an epipen in the USA ($600 for two shots from Mylan, also an american company) is also a scandal. In the UK it costs about $69. In France the cost is about $100.
www.bloomberg.com/news/articles/2016-09-...rug-pricing-itnvgvam
And then of course there is sofosbuvir from the american company called Gilead, with a discounted USA price of anywhere upwards of $40,000 per 3-month treatment. Since the raw materials now cost only about $100, this is also a scandal.
fixhepc.com/blog/itemlist/tag/production...of%20sofosbuvir.html
However, thanks to Gilead's monopoly, it is not just a USA scandal, it is a world scandal.
But is it "america bashing" to get angry about these injustices? I don't think so. There are some great americans on this site, like Mike and yourself, and I'm sure many of the rest of us appreciate your input. Me, I'm going to carry on throwing my little rocks against greed and injustice whenever I can.
Anyway, in deference to your objection, I modified my previous post to name Turing Pharmaceuticals as the guilty party in that example.
Cheers,
Diagnosed Jan 2015: GT3, A0+F0/F1. Fatigue + Brain-Fog.
Started Sof+Dac from fixHepC 10-Nov-2015. NO sides.
Pre-Tx: AST 82, ALT 133, Viral Load 1 900 000.
Week4: AST 47, ALT 58. VL < 15 (unquantifiable).
Week12 (EOT): AST 30, ALT 26, VL UND
Week16 (EOT+4): AST 32, ALT 28, GGT 24, VL UND
Week28 (EOT+16): AST 26, ALT 22, GGT 24, VL UND
Ever grateful to Dr James.
Relapsed somewhere after all that... Bummer!
Jan 2018: VL 63 000 (still GT3).